Hemostatic factors in rabbit limb lymph: Relationship to mechanisms regulating extravascular coagulation

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 274, Issue 3 43-3, 1998, Pages

  Le, Dzung T ^a   Borgs, Peter ^b   Toneff, Thomas W ^c   Witte, Marlys H ^b   Rapaport, Samuel I ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Antithrombin; Factor V; Factor VIII; Tissue factor pathway inhibitor; von Willebrand factor

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; FIBRIN; FIBRIN DEGRADATION PRODUCT; FIBRINOGEN; HEMOSTATIC AGENT; PROTHROMBIN; THROMBOPLASTIN; TISSUE FACTOR PATHWAY INHIBITOR; VON WILLEBRAND FACTOR;

ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FEMALE; HEMOSTASIS; LYMPH; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; RABBIT;

EID: 33750871464     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.274.3.h769     Document Type: Article

References (33)

1. Bach, R., and D. B. Rifkin. Expression of tissue factor procoagulant activity: regulation by cytosolic calcium. Proc. Natl. Acad. Sci. USA 87: 6995-6999, 1990.
2. Bajaj, S. P., S. I. Rapaport, and C. Prodanos. A simplified procedure for purification of humay prothrombin, factor IX and factor X. Prep. Biochem. Biotechnol. 11: 397-412, 1981.
3. Bergstrom, K., and B. Werner. Proteins in human thoracic duct lymph. Studies on the distribution of some proteins between lymph and blood. Acta Chir. Scand. 131: 413-422, 1966.
4. Blomstrand, R., I. M. Nilsson, and O. Dahlback. Coagulation studies on human thoracic duct lymph. Scand. J. Clin. Lab. Invest. 15: 248-254, 1963.
5. Brinkhous, K. M., and S. A. Walker. Prothrombin and fibrinogen in lymph. Am. J. Physiol. 132: 666-669, 1941.
6. Burke, P. E., C. F. Harvey, C. L. Phythian, C. A. Gervin, and L. J. Greenfield. Activity and transport of antithrombin during acute limb ischemia. J. Vasc. Surg. 9: 740-746, 1989.
7. Chang, P., D. L. Aronson, D. G. Borenstein, and C. M. Kessler. Coagulant proteins and thrombin generation in synovial fluid: a model for extravascular coagulation. Am. J. Hematol. 50: 79-83, 1995.
8. Chrobak, L., V. Bartos, V. Brzek, and D. Hnizdova. Coagulation properties of human thoracic duct lymph. Am. J. Med. Sci. 253: 69-75, 1967.
9. Clauss, A. Gerinnungs physiologishe schnell Methode zur bestimmung des Fibrinogens. Acta Haematol. 17: 237-246, 1957.
10. Courtice, F. C., and B. Morris. The exchange of lipids between plasma and lymph of animals. Q. J. Exp. Physiol. 40: 138-148, 1955.
11. Drake, T. A., J. H. Morrissey, and T. S. Edgington. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am. J. Pathol. 134: 1087-1097, 1989.
12. Dvorak, H. N., D. R. Senger, A. M. Dvorak, V. S. Harvey, and J. McDonagh. Regulation of extravascular coagulation by microvascular permeability. Science 227: 1059-1061, 1985.
13. Engeset, A., W. Olszewski, P. M. Jaeger, J. Sokolowski, and L. Theodorsen. Twenty-four hour variation in flow and composition of leg lymph in normal men. Acta Physiol. Scand. 99: 140-148, 1977.
14. Fleck, R. A., L. V. Rao, S. I. Rapaport, and N. Varki. Localization of human tissue factor antigen by immunostaining with monospecific, polyclonal anti-human tissue factor antibody. Thromb. Res. 59: 421-437, 1990.
15. Langdell, R. D., L. W. Bowersox, R. A. Weaver, and W. S. Gibson. Coagulation properties of canine thoracic-duct lymph. Am. J. Physiol. 199: 626-628, 1960.
16. Le, D. T., S. I. Rapaport, and L. V. Rao. Relations between factor VIIa binding and expression of factor VIIa/tissue factor catalytic activity on cell surfaces. J. Biol. Chem. 267: 15447-15454, 1992.
17. Le, D. T., S. I. Rapaport, and L. V. Rao. Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X on fibroblast monolayers after their exposure to N-ethylmaleimide. Thromb. Haemost. 72: 848-855, 1994.
18. Olszewski, W. On the pathomechanism of development of postsurgical lymphedema. Lymphology 6: 35-51, 1973.
19. Olszewski, W. L., A. Engeset, and H. Lukasiewicz. Immunoglobulins, complement and lysozyme in leg lymph of normal men. Scand. J. Clin. Lab. Invest. 37: 669-674, 1977.
20. Otsuki, Y., H. Kubo, and S. Magari. Immunohistochemical differentiation between lymphatic vessels and blood vessels-use of anti-basement membrane antibodies and anti-factor VIII-related antigen. Arch. Histol. Cytol. 53, Suppl.: 95-105, 1990.
21. Rao, L. V., O. Nordfang, A. D. Hoang, and U. R. Pendurthi. Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/ tissue factor activity. Blood 85: 121-129, 1995.
22. Rao, L. V., T. Williams, and S. I. Rapaport. Studies of the activation of factor VII bound to tissue factor. Blood 87: 3738-3748, 1996.
23. Rapaport, S. I., T. Toneff, A. Rimon, and B. J. Warn-Cramer. The effect of immunodepletion of antithrombin III on the response of rabbits to Russell's viper venom-induced activation of factor X. Arterioscler. Thromb. Vasc. Biol. 17: 409-416, 1997.
24. Seligsohn, U., C. K. Kasper, B. Osterud, and S. I. Rapaport. Activated factor VII: presence in factor IX concentrates and persistence in the circulation after infusion. Blood 53: 828-837, 1979.
25. Simionescu, M., L. Ghitescu, A. Fixman, and N. Simionescu. How plasma macromolecules cross the endothelium. News Physiol. Sci. 2: 97-100, 1987.
26. Sporn, L. A., V. J. Marder, and D. D. Wagner. Von Willebrand factor released from Weibel-Palade bodies binds more avidly to extracellular matrix than that secreted constitutively. Blood 69: 1531-1534, 1987.
27. Stutman, L. J., A. E. Dumont, and G. Y. Shinowara. Coagulation factors in human lymph and plasma. Am. J. Med. Sci. 250: 292-297, 1965.
28. Wagner, D. D., M. Urban-Pickering, and V. J. Marder. Von Willebrand protein binds to extracellular matrices independently of collagen. Proc. Natl. Acad. Sci. USA 81: 471-475, 1984.
29. Warn-Cramer, B. J., and S. L. Maki. Purification of tissue factor pathway inhibitor (TFPI) from rabbit plasma and characterization of its differences from TFPI isolated from human plasma. Thromb. Res. 67: 367-383, 1992.
30. Warn-Cramer, B. J., S. L. Maki, and S. I. Rapaport. Heparin-releasable and platelet pools of tissue factor pathway inhibitor in rabbits. Thromb. Haemost. 69: 221-226, 1993.
31. Warn-Cramer, B. J., and S. I. Rapaport. Evidence suggestive of activation of the intrinsic pathway of blood coagulation after injection of factor Xa/phospholipid into rabbits. Arterioscler. Thromb. Vasc. Biol. 15: 133-139, 1995.
32. Warr, T. A., L. V. Rao, and S. I. Rapaport. A sensitive, accurate assay for extrinsic pathway inhibitor (EPI) activity in rabbit plasma: paradoxical effect of excess exogenous factor X. Thromb. Res. 59: 773-782, 1990.
33. Zivelin, A., L. V. Rao, and S. I. Rapaport. Mechanism of the anticoagulant effect of warfarin as evaluated in rabbits by selective depression of individual procoagulant vitamin K-dependent clotting factors. J. Clin. Invest. 92: 2131-2140, 1993.